Literature DB >> 24279384

The effects of aging on apoptosis following myocardial infarction.

Andrew J Boyle1, Joy Hwang, Jianqin Ye, Henry Shih, Kristine Jun, Yan Zhang, Qizhi Fang, Richard Sievers, Yerem Yeghiazarians, Randall J Lee.   

Abstract

BACKGROUND: Aging is associated with higher incidence of heart failure and death following myocardial infarction (MI). The molecular and cellular changes that lead to these worse outcomes are not known. METHODS AND
RESULTS: Young and aging mice underwent induction of MI by LAD ligation. There was a significant increase in mortality in the aging mice. Neither the young nor aging hearts after MI had inducible ventricular tachycardia. Cardiomyocyte apoptosis increases early after MI in young and aging mice, but to a much greater degree in the aging mice. Caspase inhibition with Ac-DEVD-CHO resulted in a 61% reduction in activated caspase-3 and an 84% reduction in apoptosis in cardiomyocytes in young mice (P < 0.05), but not in aging mice. Gene pathway profiling demonstrated activation of both the caspase and Map3k1/Mapk10 pathways in aging mice following MI, which may contribute to their resistance to caspase inhibition.
CONCLUSIONS: Aging hearts activate distinct apoptotic pathways have more cardiomyocyte apoptosis and are resistant to antiapoptotic therapies following MI. Novel or combination approaches may be required to improve outcomes in aging patients following MI.
© 2013 John Wiley & Sons Ltd.

Entities:  

Keywords:  Aging; Apoptosis; Cardiomyocyte; Heart failure; Ventricular remodeling

Mesh:

Substances:

Year:  2013        PMID: 24279384      PMCID: PMC3895658          DOI: 10.1111/1755-5922.12043

Source DB:  PubMed          Journal:  Cardiovasc Ther        ISSN: 1755-5914            Impact factor:   3.023


  23 in total

1.  Myocardial improvement with human embryonic stem cell-derived cardiomyocytes enriched by p38MAPK inhibition.

Authors:  Yerem Yeghiazarians; Meenakshi Gaur; Yan Zhang; Richard E Sievers; Carissa Ritner; Megha Prasad; Andrew Boyle; Harold S Bernstein
Journal:  Cytotherapy       Date:  2011-10-31       Impact factor: 5.414

Review 2.  The aging heart and post-infarction left ventricular remodeling.

Authors:  Henry Shih; Brian Lee; Randall J Lee; Andrew J Boyle
Journal:  J Am Coll Cardiol       Date:  2011-01-04       Impact factor: 24.094

3.  Cytokine combination therapy with long-acting erythropoietin and granulocyte colony stimulating factor improves cardiac function but is not superior than monotherapy in a mouse model of acute myocardial infarction.

Authors:  Yerem Yeghiazarians; Muhammad Khan; Franca S Angeli; Yan Zhang; Sarah Jahn; Megha Prasad; Rachel Mirsky; Henry Shih; Petros Minasi; Andrew Boyle; William Grossman
Journal:  J Card Fail       Date:  2010-05-04       Impact factor: 5.712

4.  Bone marrow mesenchymal stem cells stimulate cardiac stem cell proliferation and differentiation.

Authors:  Konstantinos E Hatzistergos; Henry Quevedo; Behzad N Oskouei; Qinghua Hu; Gary S Feigenbaum; Irene S Margitich; Ramesh Mazhari; Andrew J Boyle; Juan P Zambrano; Jose E Rodriguez; Raul Dulce; Pradip M Pattany; David Valdes; Concepcion Revilla; Alan W Heldman; Ian McNiece; Joshua M Hare
Journal:  Circ Res       Date:  2010-07-29       Impact factor: 17.367

5.  Additive effects of endothelial progenitor cells combined with ACE inhibition and beta-blockade on left ventricular function following acute myocardial infarction.

Authors:  Andrew J Boyle; Michael Schuster; Piotr Witkowski; Guosheng Xiang; Tetsunori Seki; Kerrie Way; Silviu Itescu
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2005-03       Impact factor: 1.636

6.  Heart failure and greater infarct expansion in middle-aged mice: a relevant model for postinfarction failure.

Authors:  Kenneth E Gould; George E Taffet; Lloyd H Michael; Robert M Christie; Debra L Konkol; Jennifer S Pocius; Justin P Zachariah; Damian F Chaupin; Sherita L Daniel; George E Sandusky; Craig J Hartley; Mark L Entman
Journal:  Am J Physiol Heart Circ Physiol       Date:  2002-02       Impact factor: 4.733

7.  Cardiomyopathy of aging in the mammalian heart is characterized by myocardial hypertrophy, fibrosis and a predisposition towards cardiomyocyte apoptosis and autophagy.

Authors:  Andrew J Boyle; Henry Shih; Joy Hwang; Jianqin Ye; Brian Lee; Yan Zhang; David Kwon; Kristine Jun; Daiwei Zheng; Rich Sievers; Franca Angeli; Yerem Yeghiazarians; Randall Lee
Journal:  Exp Gerontol       Date:  2011-03-03       Impact factor: 4.032

8.  Aging-related defects are associated with adverse cardiac remodeling in a mouse model of reperfused myocardial infarction.

Authors:  Marcin Bujak; Hyuk Jung Kweon; Khaled Chatila; Na Li; George Taffet; Nikolaos G Frangogiannis
Journal:  J Am Coll Cardiol       Date:  2008-04-08       Impact factor: 24.094

9.  Age-related increase in mortality among patients with first myocardial infarctions treated with thrombolysis. The Investigators of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI-2).

Authors:  A P Maggioni; A Maseri; C Fresco; M G Franzosi; F Mauri; E Santoro; G Tognoni
Journal:  N Engl J Med       Date:  1993-11-11       Impact factor: 91.245

10.  Aging Impairs the Proliferative Capacity of Cardiospheres, Cardiac Progenitor Cells and Cardiac Fibroblasts: Implications for Cell Therapy.

Authors:  Jianqin Ye; Douglas S Hom; Joy Hwang; Yerem Yeghiazarians; Randall J Lee; Andrew J Boyle
Journal:  J Clin Med       Date:  2013-09-23       Impact factor: 4.241

View more
  7 in total

1.  Aging is protective against pressure overload cardiomyopathy via adaptive extracellular matrix remodeling.

Authors:  Xiaoyong Geng; Joy Hwang; Jianqin Ye; Henry Shih; Brianna Coulter; Crystal Naudin; Kristine Jun; Richard Sievers; Yerem Yeghiazarians; Randall J Lee; Andrew J Boyle
Journal:  Am J Cardiovasc Dis       Date:  2017-06-15

2.  Deoxynivalenol induces caspase-3/GSDME-dependent pyroptosis and inflammation in mouse liver and HepaRG cells.

Authors:  Xiaoxiao Mao; Jie Li; Xin Xie; Shuang Chen; Qiang Huang; Peiqiang Mu; Jun Jiang; Yiqun Deng
Journal:  Arch Toxicol       Date:  2022-08-04       Impact factor: 6.168

Review 3.  Nanocarrier-Based Targeted Therapies for Myocardial Infarction.

Authors:  Thomashire A George; Chuan-Chih Hsu; Annette Meeson; David J Lundy
Journal:  Pharmaceutics       Date:  2022-04-25       Impact factor: 6.525

Review 4.  The Dual Role of Inducible Nitric Oxide Synthase in Myocardial Ischemia/Reperfusion Injury: Friend or Foe?

Authors:  Xin Yu; Liang Ge; Liang Niu; Xin Lian; Haichun Ma; Lei Pang
Journal:  Oxid Med Cell Longev       Date:  2018-10-28       Impact factor: 6.543

5.  Novel role of extracellular matrix protein 1 (ECM1) in cardiac aging and myocardial infarction.

Authors:  Sean A Hardy; Nishani S Mabotuwana; Lucy A Murtha; Brianna Coulter; Sonia Sanchez-Bezanilla; Mohammed S Al-Omary; Tharindu Senanayake; Svenja Loering; Malcolm Starkey; Randall J Lee; Peter P Rainer; Philip M Hansbro; Andrew J Boyle
Journal:  PLoS One       Date:  2019-02-21       Impact factor: 3.240

Review 6.  Therapeutic Potential of Senolytics in Cardiovascular Disease.

Authors:  Emily Dookun; João F Passos; Helen M Arthur; Gavin D Richardson
Journal:  Cardiovasc Drugs Ther       Date:  2020-09-26       Impact factor: 3.727

Review 7.  Senescence and senolytics in cardiovascular disease: Promise and potential pitfalls.

Authors:  W Andrew Owens; Anna Walaszczyk; Ioakim Spyridopoulos; Emily Dookun; Gavin D Richardson
Journal:  Mech Ageing Dev       Date:  2021-07-06       Impact factor: 5.432

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.